首页|Nanotechnology Integrated Innovative Drug Delivery and Therapy for Cancer

Nanotechnology Integrated Innovative Drug Delivery and Therapy for Cancer

扫码查看
Cancer remains a significant global health challenge, necessitating innovative approaches to enhance the efficacy and specificity of therapeutic interventions while minimizing adverse effects on healthy tissues. Nanotechnology has emerged as a promising avenue in cancer treatment, offering novel strategies for targeted drug delivery. Nanoparticles, liposomes, and polymer-based systems have played pivotal roles in revolutionizing cancer therapy. Nanotechnology possesses unique physicochemical properties, enabling efficient encapsulation of therapeutic agents and controlled and prolonged release at tumour sites. Advancement in formulations using nanotechnology has made it possible to make multifunctional systems that respond to the microenvironment of a tumour by releasing payloads in response to changes in pH, temperature, or enzymes. Stimuli-responsive polymers can release drugs in response to external cues, enabling site-specific drug release and minimizing systemic exposure. This review explores recent studies and preclinical trials that show how nanoparticles, liposomes, and polymer-based systems could be used to treat cancer, discussing challenges such as scalability, regulatory approval, and potential toxicity concerns along with patents published recently.

Nanotechnologytargeted drug deliverynanoparticlesliposomespolymer-based systemstherapeutic outcomesdendrimers

Romulo R. Macadangdang Jr.、Rutvi Agrawal、Bharat Bhushan、Akash Garg、Kuldeep Singh、Shivendra Kumar、Atul Kumar

展开 >

Department of Nursing, College of Allied Health, National University, Manila, Philippines

Department of Pharmaceutics, Rajiv Academy for Pharmacy, Mathura, Uttar Pradesh, India

Department of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India

Department of Pharmacology, Rajiv Academy for Pharmacy, Mathura, Uttar Pradesh, India

展开 >

2025

Current pharmaceutical biotechnology

Current pharmaceutical biotechnology

SCI
ISSN:1389-2010
年,卷(期):2025.26(8)
  • 151